Cary, North Carolina–based Thread has introduced a consultative service known as Thread Adopt to support change management in decentralized clinical trials.
The service encompasses processes, tools, templates and educational functionality.
“Thread Adopt guides and empowers customers to analyze their pipeline, with a view to match decentralized solutions and services to the specific needs of their trials,” said Dr. Christopher Watson, the company’s director of consulting, in a statement.
In late August, Thread announced a partnership with Endpoint Clinical, a provider of interactive response technology for clinical trials, to help clients streamline decentralized clinical trial operations.
The partnership supports two-way integration for eConsent, screening and randomization, while providing automation of workflows across both companies’ respective platforms.
Filed Under: clinical trials, Drug Discovery